Non-invasive Prenatal Testing Market Key Vendors, Trends and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Non-invasive Prenatal Testing Market covers analysis By Product (Assay Kits and Reagents, Consumables, Disposables, Next-Generation Sequencing System, Instruments, PCR instruments, Ultrasound Devices, Microarrays, others); Method (Ultrasound Detection, Cell-Free DNA in Maternal Plasma Tests, Biochemical Screening Tests, Fetal Cells in Maternal Plasma Tests); Application (Trisomy, Micro Deletion Syndrome, Others); End User (Diagnostic Laboratories, Hospitals), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00005191
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION


Non-invasive Prenatal Testing is a new genetic process that examines the fetal cell-free DNA present in the mother's blood serum for the detection of common fetal aneuploidies.

MARKET DYNAMICS


The Non-invasive Prenatal Testing market is anticipated to grow in the forecast, owing to the factors such as growing reimbursements for the NIPT sector, increasing shift from invasive methods to noninvasive methods, growth in the risk of chromosomal abnormalities in babies, launch and development of advanced and novel technologies and growing maternal age. Nevertheless, lack of skilled professionals and stringent regulatory guidelines is expected to hamper the market growth during the forecast period.

MARKET SCOPE


The "Global Non-invasive Prenatal Testing Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Non-invasive Prenatal Testing market with detailed market segmentation by Product, Method, Application, End User and geography. The global Non-invasive Prenatal Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Non-invasive Prenatal Testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION


The global Non-invasive Prenatal Testing market is segmented on the basis of Product, Method, Application and End User. Based on Product the market is segmented into Assay Kits and Reagents, Consumables, Disposables, Next-Generation Sequencing System, Instruments, PCR instruments, Ultrasound Devices, Microarrays, others. Based on Method the market is segmented into Ultrasound Detection, Cell-Free DNA in Maternal Plasma Tests, Biochemical Screening Tests, Fetal Cells in Maternal Plasma Tests. Based on Application the market is segmented into Trisomy, Micro Deletion Syndrome, Others. Based on End User the market is segmented into Diagnostic Laboratories, Hospitals.
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Non-invasive Prenatal Testing market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Non-invasive Prenatal Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Non-invasive Prenatal Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Non-invasive Prenatal Testing market in these regions.

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MARKET PLAYERS


The reports cover key developments in the Non-invasive Prenatal Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Non-invasive Prenatal Testing market are anticipated to lucrative growth opportunities in the future with the rising demand for Non-invasive Prenatal Testing market in the global market. Below mentioned is the list of few companies engaged in the Non-invasive Prenatal Testing market.

The report also includes the profiles of Non-invasive Prenatal Testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Ge Healthcare
  • Koninklijke Philips N.V
  • Illumina, Inc
  • Thermo Fisher Scientific, Inc
  • F. Hoffman-La Roche Ltd
  • Pacific Biosciences of California, Inc
  • Perkinelmer, Inc
  • Qiagen N.V
  • Agilent Technologies, Inc
  • BGI
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Non-invasive Prenatal Testing Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Assay Kits and Reagents
  • Consumables
  • Disposables
  • Next-Generation Sequencing System
  • Instruments
  • PCR instruments
  • Ultrasound Devices
  • Microarrays
By Method
  • Ultrasound Detection
  • Cell-Free DNA in Maternal Plasma Tests
  • Biochemical Screening Tests
  • Fetal Cells in Maternal Plasma Tests
By Application
  • Trisomy
  • Micro Deletion Syndrome
By End User
  • Diagnostic Laboratories
  • Hospitals
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Ge Healthcare
  • Koninklijke Philips N.V
  • Illumina, Inc
  • Thermo Fisher Scientific, Inc
  • F. Hoffman-La Roche Ltd
  • Pacific Biosciences of California, Inc
  • Perkinelmer, Inc
  • Qiagen N.V
  • Agilent Technologies, Inc
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    non-invasive-prenatal-testing-market-report-deliverables-img1
    non-invasive-prenatal-testing-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    - Ge Healthcare
    - Koninklijke Philips N.V
    - Illumina, Inc
    - Thermo Fisher Scientific, Inc
    - F. Hoffman-La Roche Ltd
    - Pacific Biosciences of California, Inc
    - Perkinelmer, Inc
    - Qiagen N.V
    - Agilent Technologies, Inc
    - BGI
    non-invasive-prenatal-testing-market-cagr